Inactive Instrument

Analyst Reco. Fennec Pharmaceuticals Inc. Nasdaq

Equities

CA31447P1009

Real-time Estimate Cboe BZX Other stock markets 14:40:17 17/07/2024 BST			5-day change	1st Jan Change
6.81 ^USD	0.00%		0.00%	0.00%

07-02	MT Newswires Weekend Stocks To Watch: BCE; Bitfarms; Fennec; GreenPower; Hut 8; Restaurant Brands; Sigma Lithium; Solaris	MT
07-01	Fennec Pharmaceuticals Chief Operating Officer Adrian Haigh Steps Down	MT

Analyst Reco.

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

HC Wainwright Adjusts Fennec Pharmaceuticals Price Target to $15 From $18, Maintains Buy Rating	05-15	MT
Fennec Pharmaceuticals Insider Sold Shares Worth $433,996, According to a Recent SEC Filing	04-19	MT
Fennec Pharmaceuticals Insider Sold Shares Worth $457,182, According to a Recent SEC Filing	04-17	MT
Fennec Pharmaceuticals Insider Sold Shares Worth $958,669, According to a Recent SEC Filing	04-05	MT
HC Wainwright Raises Fennec Pharmaceuticals Price Target to $18 From $17, Maintains Buy Rating	04-04	MT
Fennec Pharmaceuticals Insider Sold Shares Worth $437,451, According to a Recent SEC Filing	04-03	MT
HC Wainwright Adjusts Price Target on Fennec Pharmaceuticals to $17 From $18, Maintains Buy Rating	04/08/23	MT
Cantor Fitzgerald Adjusts Fennec Pharmaceuticals' Price Target to $16 From $12	06/04/23	MT
Wedbush Adjusts Fennec Pharmaceuticals Price Target to $16 From $17, Maintains Outperform Rating	30/03/23	MT
Wedbush Lowers Fennec Pharmaceuticals' Price Target to $17 From $19, Maintains Outperform Rating	25/01/23	MT
Cantor Fitzgerald Upgrades Fennec Pharmaceuticals to Overweight From Neutral, Adjusts Price Target to $12 From $9	22/11/22	MT
HC Wainwright Adjusts Fennec Pharmaceuticals' Price Target to $18 From $14, Keeps Buy Rating	20/10/22	MT
Maxim Adjusts Fennec Pharmaceuticals' Price Target to $15 from $10, Maintains Buy	29/09/22	MT
Wedbush Adjusts Fennec Pharmaceuticals Price Target to $19 From $11, Maintains Outperform Rating	26/09/22	MT
Capital One Starts Fennec Pharmaceuticals at Overweight With $11 Price Target	07/09/22	MT
Craig-Hallum Assumes Fennec Pharmaceuticals at Buy With $14 Price Target	08/08/22	MT
Wedbush Maintains Outperform, Raises Fennec Pharmaceuticals' TP to US$11	12/05/22	MT
Wedbush Lifts Price Target for Fennec Pharmaceuticals to $11 From $10, Maintains Outperform Rating	12/05/22	MT
Wedbush Maintains Outperform, US$10 TP on Fennec Pharmaceuticals After Q4, Pedmark Update	28/02/22	MT
Wedbush Lifts Price Target for Fennec Pharmaceuticals to $10 From $9, Maintains Outperform Rating	28/02/22	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Analyst Reco. Fennec Pharmaceuticals Inc. Nasdaq

Equities

CA31447P1009

Analyst Reco.

Filters